- Home
- CPBI vs CTSO Comparison
CPBI vs CTSO Comparison
Compare CPBI & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPBI
- CTSO
- Stock Information
- Founded
- CPBI 2023
- CTSO 1997
- Country
- CPBI United States
- CTSO United States
- Employees
- CPBI N/A
- CTSO N/A
- Industry
- CPBI
- CTSO Medical/Dental Instruments
- Sector
- CPBI
- CTSO Health Care
- Exchange
- CPBI Nasdaq
- CTSO Nasdaq
- Market Cap
- CPBI 56.2M
- CTSO 61.3M
- IPO Year
- CPBI N/A
- CTSO N/A
- Fundamental
- Price
- CPBI $15.00
- CTSO $1.04
- Analyst Decision
- CPBI
- CTSO Strong Buy
- Analyst Count
- CPBI 0
- CTSO 3
- Target Price
- CPBI N/A
- CTSO $4.67
- AVG Volume (30 Days)
- CPBI 9.6K
- CTSO 90.8K
- Earning Date
- CPBI 01-01-0001
- CTSO 05-08-2025
- Dividend Yield
- CPBI N/A
- CTSO N/A
- EPS Growth
- CPBI 29.70
- CTSO N/A
- EPS
- CPBI 1.62
- CTSO N/A
- Revenue
- CPBI $18,546,000.00
- CTSO $37,739,531.00
- Revenue This Year
- CPBI N/A
- CTSO $9.20
- Revenue Next Year
- CPBI N/A
- CTSO $11.64
- P/E Ratio
- CPBI $9.11
- CTSO N/A
- Revenue Growth
- CPBI 13.73
- CTSO 1.80
- 52 Week Low
- CPBI $9.96
- CTSO $0.70
- 52 Week High
- CPBI $15.50
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- CPBI 63.67
- CTSO 47.52
- Support Level
- CPBI $14.80
- CTSO $0.97
- Resistance Level
- CPBI $14.81
- CTSO $1.14
- Average True Range (ATR)
- CPBI 0.08
- CTSO 0.08
- MACD
- CPBI 0.02
- CTSO -0.01
- Stochastic Oscillator
- CPBI 100.00
- CTSO 38.14
About CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists primarily of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in our primary market area, as well as commercial real estate loans.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.